MediFind
Condition

Renal Oncocytoma

Latest Research

Latest Advance
Study
  • Condition: HER2-positive Gastro-oesophageal Adenocarcinoma
  • Journal: The Lancet. Oncology
  • Treatment Used: Margetuximab plus Pembrolizumab
  • Number of Patients: 95
  • Published —
The study researched the use of Margetuximab plus Pembrolizumab for treating HER2-positive gastro-oesophageal adenocarcinoma.
Latest Advance
Study
  • Condition: HER2-Positive Gastric Cancer
  • Journal: The New England journal of medicine
  • Treatment Used: Trastuzumab Deruxtecan
  • Number of Patients: 187
  • Published —
The study researched the safety and effectiveness of Trastuzumab Deruxtecan in treating HER2-positive gastric cancer.
Latest Advance
Study
  • Condition: Collision Cancer of Primary Squamous Cell Carcinoma (SCC) and Adenocarcinoma in Stomach after Treatment for Non-Hodgkin's Lymphoma of Diffuse Large B Cell Type
  • Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
  • Treatment Used: Total Gastrectomy, Distal Pancreatectomy, Splenectomy, D2 Lymph Node Dissection, and Adjuvant Chemotherapy
  • Number of Patients: 1
  • Published —
This case report discusses a 61-year-old woman with a collision cancer of primary squamous cell carcinoma (SCC) and adenocarcinoma in the stomach treated with total gastrectomy, distal pancreatectomy, splenectomy, D2 lymph node dissection, and adjuvant chemotherapy with S-1.
Latest Advance
Study
  • Condition: Siewert type II adenocarcinoma of esophagogastric junction
  • Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
  • Treatment Used: Cheng's Giraffe reconstruction
  • Number of Patients: 34
  • Published —
The study researched the effects of Cheng's Giraffe reconstruction on patients with Siewert type II adenocarcinoma of esophagogastric junction.
Latest Advance
Study
  • Condition: Pre-treated Patients with Epidermal Growth-Factor Receptor (EGFR)-Mutated or Anaplastic Lymphoma Kinase (ALK)-Translocated Lung Adenocarcinoma
  • Journal: Medicine
  • Treatment Used: Programmed Cell-Death-Protein-1 and Its Ligand Inhibitors
  • Number of Patients: 51
  • Published —
This study determined the effectiveness against epidermal growth-factor receptor (EGFR)/anaplastic lymphoma kinase (ALK)/c-ros oncogene 1 (ROS1)-mutated non-small cell lung cancer (NSCLC).
Latest Advance
Study
  • Condition: Locally advanced pulmonary adenocarcinoma
  • Journal: Medicine
  • Treatment Used: Neoadjuvant apatinib plus S-1
  • Number of Patients: 1
  • Published —
The study researched the effects of neoadjuvant apatinib plus S-1 for locally advanced pulmonary adenocarcinoma.
Latest Advance
Study
  • Condition: 6-Year-Old Child with Clear Cell Adenocarcinoma of the Cervix (CCAC)
  • Journal: Medicine
  • Treatment Used: Fertility-Preserving Local Excision under Hysteroscope with Combined Chemotherapy (CT)
  • Number of Patients: 1
  • Published —
This case report discusses a a 6-year-old child with clear cell adenocarcinoma of the cervix treated with fertility-preserving local excision under a hysteroscope with combined chemotherapy (CT).
Latest Advance
Study
  • Condition: Gastric Adenocarcinoma
  • Journal: Journal of surgical oncology
  • Treatment Used: Multivisceral Resection vs Standard Gastrectomy
  • Number of Patients: 524
  • Published —
In this study, researchers compared the effectiveness of multivisceral resection versus standard gastrectomy for the treatment of gastric adenocarcinomas.
Latest Advance
Study
  • Condition: Pancreatic Tumors in Children
  • Journal: Pediatric surgery international
  • Treatment Used: Surgical Resection
  • Number of Patients: 109
  • Published —
This study described patient and tumor characteristics and to report on survival of pancreatic tumors in children.
Latest Advance
Study
  • Condition: Gastric Cancer
  • Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • Treatment Used: Cetuximab and Cisplatin
  • Number of Patients: 122
  • Published —
This study evaluated the effectiveness of cetuximab combine with cisplatin in patients with gastric cancer.
Latest Advance
Study
  • Condition: Metastatic Colorectal Cancer
  • Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • Treatment Used: Cepecitabine plus Temozolamide vs. Regorafenib
  • Number of Patients: 15
  • Published —
This study compared regorafenib versus capecitabine plus temozolamide in patients with metastatic colorectal cancer.
Latest Advance
Study
  • Condition: Siewert Type II Adenocarcinoma of the Esophagogastric Junction
  • Journal: Disease markers
  • Treatment Used: Proximal Gastrectomy versus Total Gastrectomy
  • Number of Patients: 2217
  • Published —
The study researched the effects of proximal gastrectomy versus total gastrectomy for Siewert Type II adenocarcinoma of the esophagogastric junction.